Amneal moves to dismiss US price-fixing claims over bethanechol chloride tablets
MLex Summary: Amneal Pharmaceuticals moved to dismiss US price-fixing claims over bethanechol chloride tablets filed by self-funded direct-action plaintiffs, saying the complaint only alleges at most two facts supposedly implicating Amneal...To view the full article, register now.
Already a subscriber? Click here to view full article